The expression levels of MicroRNA-146a, RANKL and OPG after non-surgical periodontal treatment.


Journal

BMC oral health
ISSN: 1472-6831
Titre abrégé: BMC Oral Health
Pays: England
ID NLM: 101088684

Informations de publication

Date de publication:
13 10 2021
Historique:
received: 07 06 2021
accepted: 05 10 2021
entrez: 14 10 2021
pubmed: 15 10 2021
medline: 3 11 2021
Statut: epublish

Résumé

MicroRNA-146a (miR-146a) is a regulator of inflammatory response. Periodontitis is a disease with immune pathophysiology of the periodontium in which the inflammation results in the destruction of the soft tissues and alveolar bone. Therefore, the aim of this study was to investigate the expressions of miR-146a, OPG, and RANKL in diseased and healthy periodontal tissues to understand whether miR-146a expression level may associate with OPG and RANKL mRNA levels and OPG/RANKL ratio after non-surgical periodontal treatment. The levels of miR-146a, RANKL, and OPG in gingival tissues from patients with generalized periodontitis stages II and III and grades A and B (n = 15, group A), patients with generalized periodontitis stages III and IV and grade C (n = 15, group B), and healthy individuals (n = 10) were determined by real-time PCR. The associations of miR-146a expression with OPG and RANKL levels were evaluated. The levels of miR-146a in two subgroups within periodontitis patients were significantly higher than healthy subjects (P < 0.0001). MiR-146a showed the increased level in group A of patients compared with group B (P < 0.05). Clinical parameters such as probing depth (PD) and clinical attachment loss (CAL) were significantly higher in patients than control group (P < 0.05). The levels of OPG and RANKL were increased in patients compared with healthy subjects, although the elevated levels were not statistically significant. MiR-146a was not associated with OPG and RANKL levels and OPG/RANKL ratio. The results of this study failed to show the associations of miR-146a level with OPG and RANKL levels and OPG/RANKL ratio in periodontitis after non-surgical periodontal treatment.

Identifiants

pubmed: 34645448
doi: 10.1186/s12903-021-01883-8
pii: 10.1186/s12903-021-01883-8
pmc: PMC8515652
doi:

Substances chimiques

MIRN146 microRNA, human 0
MicroRNAs 0
Osteoprotegerin 0
RANK Ligand 0
TNFRSF11B protein, human 0
TNFSF11 protein, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

523

Informations de copyright

© 2021. The Author(s).

Références

J Periodontol. 2015 Dec;86(12):1380-5
pubmed: 26313020
FEBS J. 2011 May;278(10):1619-33
pubmed: 21395978
Acta Odontol Scand. 2012 Dec;70(6):629-34
pubmed: 22214279
J Clin Microbiol. 2009 Jun;47(6):1705-11
pubmed: 19386852
J Immunol Res. 2019 Apr 28;2019:6195258
pubmed: 31183390
J Can Dent Assoc. 2000 Dec;66(11):594-7
pubmed: 11253351
Inflammation. 2010 Jun;33(3):200-6
pubmed: 20033478
J Periodontol. 2021 May 19;:
pubmed: 34008185
Cell. 2005 Jan 14;120(1):15-20
pubmed: 15652477
Oral Dis. 2010 May;16(4):360-4
pubmed: 20233326
Biochim Biophys Acta Mol Basis Dis. 2018 Mar;1864(3):925-933
pubmed: 29288795
Arch Oral Biol. 2021 Feb;122:104997
pubmed: 33291049
J Dent Res. 2004 Feb;83(2):166-9
pubmed: 14742657
J Clin Periodontol. 2018 Jun;45 Suppl 20:S1-S8
pubmed: 29926489
Cytokine Growth Factor Rev. 2004 Feb;15(1):49-60
pubmed: 14746813
Clin Cosmet Investig Dent. 2019 Aug 14;11:251-257
pubmed: 31616190
Shanghai Kou Qiang Yi Xue. 2018 Jun;27(3):309-312
pubmed: 30411131
Semin Oncol. 2011 Dec;38(6):724-33
pubmed: 22082758
Mol Biol Int. 2011;2011:437301
pubmed: 22091404
Oral Dis. 2014 Sep;20(6):616-23
pubmed: 24112124
Periodontol 2000. 1997 Jun;14:216-48
pubmed: 9567973
Cell. 2012 Apr 27;149(3):515-24
pubmed: 22541426
Diabetes. 2012 Nov;61(11):2906-12
pubmed: 22851573
J Immunol Res. 2015;2015:615486
pubmed: 26065002
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
J Cell Biochem. 2019 Aug;120(8):13861-13866
pubmed: 30989711
Int J Oral Sci. 2011 Jul;3(3):125-34
pubmed: 21789961
J Periodontol. 2019 Apr;90(4):391-399
pubmed: 30378773
J Periodontol. 2015 Jul;86(7):835-8
pubmed: 26125117
Cold Spring Harb Perspect Biol. 2009 Dec;1(6):a001651
pubmed: 20457564
Genes Dis. 2015 Mar 1;2(1):35-45
pubmed: 25984557
J Periodontal Res. 2019 Feb;54(1):27-32
pubmed: 30328616
J Periodontal Res. 2014 Aug;49(4):508-17
pubmed: 24102429
Biomed Res Int. 2015;2015:421746
pubmed: 26247020
Proc Natl Acad Sci U S A. 2006 Aug 15;103(33):12481-6
pubmed: 16885212
Biomed Res Int. 2014;2014:731039
pubmed: 24719884

Auteurs

Mandana Sattari (M)

Department of Immunology, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Ramezan Ali Taheri (RA)

Nanobiotechnology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.

Reza ArefNezhad (R)

Department of Anatomy, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.

Hossein Motedayyen (H)

Autoimmune Diseases Research Center, Shahid Beheshti Hospital, Kashan University of Medical Sciences, 5th Kilometer of Ravand Road, Kashan, Iran. hmotedayyen@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH